“Antitumor and Antimetastatic Activity of a Novel Pyrimidin-4-one Derivative in the B16–F10 Melanoma Mouse Model: A Pilot Study” (2026) Voprosy onkologii, 72(4), p. 2630. doi:10.37469/0507-3758-2026-72-4-2630.